Hm Payson & CO Thermo Fisher Scientific Inc. Transaction History

Hm Payson & CO

$5.81 Billion
Q3 2024

A detailed history of Hm Payson & CO transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Hm Payson & CO holds 154,431 shares of TMO stock, worth $80.7 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares

154,431

Previous 156,886 1.56%

Holding current value

$80.7 Million

Previous $86.8 Million 10.1%

% of portfolio

1.64%

Previous 1.58%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$531.86 - $624.21 $1.31 Million - $1.53 Million	-2,455 Reduced 1.56%	154,431 $95.5 Million
Q2 2024 Aug 13, 2024	BUY	$541.52 - $599.02 $5.76 Million - $6.38 Million	10,644 Added 7.28%	156,886 $86.8 Million
Q1 2024 Jun 20, 2024	BUY	$528.82 - $599.43 $781,595 - $885,957	1,478 Added 1.02%	146,242 $85 Million
Q4 2023 Feb 13, 2024	SELL	$431.41 - $532.94 $480,159 - $593,162	-1,113 Reduced 0.76%	144,764 $76.8 Million
Q3 2023 Nov 06, 2023	BUY	$498.29 - $574.41 $504,269 - $581,302	1,012 Added 0.7%	145,877 $73.8 Million
Q2 2023 Jul 17, 2023	BUY	$508.46 - $591.13 $1.28 Million - $1.49 Million	2,513 Added 1.77%	144,865 $75.6 Million
Q1 2023 Apr 18, 2023	SELL	$535.0 - $604.82 $241,820 - $273,378	-452 Reduced 0.32%	142,352 $82 Million
Q4 2022 Feb 06, 2023	BUY	$484.71 - $571.37 $2.03 Million - $2.39 Million	4,183 Added 3.02%	142,804 $78.7 Million
Q3 2022 Oct 25, 2022	SELL	$507.19 - $604.49 $2.6 Million - $3.1 Million	-5,127 Reduced 3.57%	138,621 $70.3 Million
Q2 2022 Aug 15, 2022	BUY	$500.9 - $612.21 $686,233 - $838,727	1,370 Added 0.96%	143,748 $78.1 Million
Q1 2022 May 12, 2022	BUY	$524.0 - $644.92 $517,712 - $637,180	988 Added 0.7%	142,378 $84.1 Million
Q4 2021 Feb 15, 2022	BUY	$569.0 - $667.24 $2.05 Million - $2.41 Million	3,608 Added 2.62%	141,390 $94.3 Million
Q3 2021 Nov 30, 2021	BUY	$509.53 - $609.78 $1.33 Million - $1.59 Million	2,609 Added 1.93%	137,782 $78.7 Million
Q2 2021 Aug 17, 2021	BUY	$441.0 - $508.24 $3.83 Million - $4.42 Million	8,694 Added 6.87%	135,173 $68.2 Million
Q1 2021 Jun 15, 2021	BUY	$439.85 - $518.83 $3.51 Million - $4.15 Million	7,991 Added 6.74%	126,479 $57.7 Million
Q4 2020 Mar 10, 2021	BUY	$435.06 - $527.66 $270,607 - $328,204	622 Added 0.53%	118,488 $55.2 Million
Q3 2020 Dec 21, 2020	BUY	$359.77 - $441.52 $3.02 Million - $3.71 Million	8,394 Added 7.67%	117,866 $52 Million
Q2 2020 Aug 13, 2020	BUY	$275.2 - $362.34 $1.62 Million - $2.14 Million	5,903 Added 5.7%	109,472 $39.7 Million
Q1 2020 Jul 01, 2020	BUY	$255.3 - $340.05 $14.8 Million - $19.7 Million	57,853 Added 126.55%	103,569 $29.4 Million
Q4 2019 Feb 18, 2020	BUY	$271.93 - $328.04 $10.1 Million - $12.1 Million	37,028 Added 426.2%	45,716 $14.9 Million
Q3 2019 Nov 12, 2019	BUY	$268.46 - $305.43 $266,580 - $303,291	993 Added 12.9%	8,688 $2.53 Million
Q2 2019 Aug 15, 2019	BUY	$257.51 - $295.55 $1.98 Million - $2.27 Million	7,695 New	7,695 $2.26 Million
Q4 2018 Feb 15, 2019	SELL	$208.47 - $251.98 $1.46 Million - $1.76 Million	-6,998 Closed	0 $0
Q3 2018 Nov 30, 2018	SELL	$205.57 - $244.32 $535,304 - $636,209	-2,604 Reduced 27.12%	6,998 $1.71 Million
Q2 2018 Aug 27, 2018	SELL	$203.14 - $219.53 $217,562 - $235,116	-1,071 Reduced 10.03%	9,602 $1.99 Million
Q1 2018 May 14, 2018	BUY	$192.98 - $224.11 $29,525 - $34,288	153 Added 1.45%	10,673 $2.2 Million
Q4 2017 Feb 16, 2018	SELL	$182.03 - $200.37 $183,850 - $202,373	-1,010 Reduced 8.76%	10,520 $2 Million
Q3 2017 Nov 06, 2017	BUY	$171.74 - $194.04 $1.98 Million - $2.24 Million	11,530	11,530 $2.18 Million

Others Institutions Holding TMO

# of Institutions

2,834

Shares Held

333M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $205B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account